367 related articles for article (PubMed ID: 17728461)
21. Intracerebroventricular enzyme infusion corrects central nervous system pathology and dysfunction in a mouse model of metachromatic leukodystrophy.
Stroobants S; Gerlach D; Matthes F; Hartmann D; Fogh J; Gieselmann V; D'Hooge R; Matzner U
Hum Mol Genet; 2011 Jul; 20(14):2760-9. PubMed ID: 21515587
[TBL] [Abstract][Full Text] [Related]
22. Metachromatic leukodystrophy without arylsulfatase A deficiency: a new case of saposin-B deficiency.
Deconinck N; Messaaoui A; Ziereisen F; Kadhim H; Sznajer Y; Pelc K; Nassogne MC; Vanier MT; Dan B
Eur J Paediatr Neurol; 2008 Jan; 12(1):46-50. PubMed ID: 17616409
[TBL] [Abstract][Full Text] [Related]
23. Sulfatide decrease in myelin influences formation of the paranodal axo-glial junction and conduction velocity in the sciatic nerve.
Hayashi A; Kaneko N; Tomihira C; Baba H
Glia; 2013 Apr; 61(4):466-74. PubMed ID: 23322453
[TBL] [Abstract][Full Text] [Related]
24. Embryonic stem cell-based reduction of central nervous system sulfatide storage in an animal model of metachromatic leukodystrophy.
Klein D; Schmandt T; Muth-Köhne E; Perez-Bouza A; Segschneider M; Gieselmann V; Brüstle O
Gene Ther; 2006 Dec; 13(24):1686-95. PubMed ID: 16871228
[TBL] [Abstract][Full Text] [Related]
25. Morphological alterations in the inner ear of the arylsulfatase A-deficient mouse.
Coenen R; Gieselmann V; Lüllmann-Rauch R
Acta Neuropathol; 2001 May; 101(5):491-8. PubMed ID: 11484821
[TBL] [Abstract][Full Text] [Related]
26. Bone marrow stem cell-based gene transfer in a mouse model for metachromatic leukodystrophy: effects on visceral and nervous system disease manifestations.
Matzner U; Hartmann D; Lüllmann-Rauch R; Coenen R; Rothert F; Månsson JE; Fredman P; D'Hooge R; De Deyn PP; Gieselmann V
Gene Ther; 2002 Jan; 9(1):53-63. PubMed ID: 11850723
[TBL] [Abstract][Full Text] [Related]
27. Olaparib Attenuates Demyelination and Neuroinflammation in an Organotypic Slice Culture Model of Metachromatic Leukodystrophy.
Mekhaeil M; Conroy MJ; Dev KK
Neurotherapeutics; 2023 Sep; 20(5):1347-1368. PubMed ID: 37525026
[TBL] [Abstract][Full Text] [Related]
28. Delay of myelin formation in arylsulphatase A-deficient mice.
Yaghootfam A; Gieselmann V; Eckhardt M
Eur J Neurosci; 2005 Feb; 21(3):711-20. PubMed ID: 15733089
[TBL] [Abstract][Full Text] [Related]
29. Sulfatide with short fatty acid dominates in astrocytes and neurons.
Isaac G; Pernber Z; Gieselmann V; Hansson E; Bergquist J; Månsson JE
FEBS J; 2006 Apr; 273(8):1782-90. PubMed ID: 16623713
[TBL] [Abstract][Full Text] [Related]
30. Potential of surfactant-coated nanoparticles to improve brain delivery of arylsulfatase A.
Schuster T; Mühlstein A; Yaghootfam C; Maksimenko O; Shipulo E; Gelperina S; Kreuter J; Gieselmann V; Matzner U
J Control Release; 2017 May; 253():1-10. PubMed ID: 28215668
[TBL] [Abstract][Full Text] [Related]
31. Metachromatic leukodystrophy: molecular genetics and an animal model.
Gieselmann V; Matzner U; Hess B; Lüllmann-Rauch R; Coenen R; Hartmann D; D'Hooge R; DeDeyn P; Nagels G
J Inherit Metab Dis; 1998 Aug; 21(5):564-74. PubMed ID: 9728336
[TBL] [Abstract][Full Text] [Related]
32. Accumulation of lysosulfatide in the brain of arylsulfatase A-deficient mice.
Blomqvist M; Gieselmann V; Månsson JE
Lipids Health Dis; 2011 Feb; 10():28. PubMed ID: 21299873
[TBL] [Abstract][Full Text] [Related]
33. Non-inhibitory antibodies impede lysosomal storage reduction during enzyme replacement therapy of a lysosomal storage disease.
Matzner U; Matthes F; Weigelt C; Andersson C; Eistrup C; Fogh J; Gieselmann V
J Mol Med (Berl); 2008 Apr; 86(4):433-42. PubMed ID: 18360747
[TBL] [Abstract][Full Text] [Related]
34. Dysfunction of platelet-derived growth factor receptor α (PDGFRα) represses the production of oligodendrocytes from arylsulfatase A-deficient multipotential neural precursor cells.
Pituch KC; Moyano AL; Lopez-Rosas A; Marottoli FM; Li G; Hu C; van Breemen R; Månsson JE; Givogri MI
J Biol Chem; 2015 Mar; 290(11):7040-53. PubMed ID: 25605750
[TBL] [Abstract][Full Text] [Related]
35. Elevated sulfatide excretion in heterozygotes of metachromatic leukodystrophy: dependence on reduction of arylsulfatase A activity.
Molzer B; Sundt-Heller R; Kainz-Korschinsky M; Zobel M
Am J Med Genet; 1992 Nov; 44(4):523-6. PubMed ID: 1359786
[TBL] [Abstract][Full Text] [Related]
36. Accumulation of sulfatide in neuronal and glial cells of arylsulfatase A deficient mice.
Molander-Melin M; Pernber Z; Franken S; Gieselmann V; Månsson JE; Fredman P
J Neurocytol; 2004 Jul; 33(4):417-27. PubMed ID: 15520527
[TBL] [Abstract][Full Text] [Related]
37. Treatment of adult metachromatic leukodystrophy model mice using intrathecal administration of type 9 AAV vector encoding arylsulfatase A.
Miyake N; Miyake K; Sakai A; Yamamoto M; Suzuki H; Shimada T
Sci Rep; 2021 Oct; 11(1):20513. PubMed ID: 34654893
[TBL] [Abstract][Full Text] [Related]
38. Fetal metachromatic leukodystrophy: pathology, biochemistry and a study of in vitro enzyme replacement in CNS tissue.
Poduslo SE; Tennekoon G; Price D; Miller K; McKhann GM
J Neuropathol Exp Neurol; 1976; 35(6):622-32. PubMed ID: 11278
[TBL] [Abstract][Full Text] [Related]
39. Coexpression of formylglycine-generating enzyme is essential for synthesis and secretion of functional arylsulfatase A in a mouse model of metachromatic leukodystrophy.
Takakusaki Y; Hisayasu S; Hirai Y; Shimada T
Hum Gene Ther; 2005 Aug; 16(8):929-36. PubMed ID: 16076251
[TBL] [Abstract][Full Text] [Related]
40. Sulfatide in health and disease. The evaluation of sulfatide in cerebrospinal fluid as a possible biomarker for neurodegeneration.
Blomqvist M; Zetterberg H; Blennow K; Månsson JE
Mol Cell Neurosci; 2021 Oct; 116():103670. PubMed ID: 34562592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
